Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 372

1.

Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.

Schurek KN, Marr AK, Taylor PK, Wiegand I, Semenec L, Khaira BK, Hancock RE.

Antimicrob Agents Chemother. 2008 Dec;52(12):4213-9. doi: 10.1128/AAC.00507-08. Epub 2008 Sep 29.

PMID:
18824604
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.

Krahn T, Gilmour C, Tilak J, Fraud S, Kerr N, Lau CH, Poole K.

Antimicrob Agents Chemother. 2012 Nov;56(11):5591-602. doi: 10.1128/AAC.01446-12. Epub 2012 Aug 20.

PMID:
22908149
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Aminoglycoside antibiotics induce bacterial biofilm formation.

Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI.

Nature. 2005 Aug 25;436(7054):1171-5.

PMID:
16121184
[PubMed - indexed for MEDLINE]
4.

Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.

Field TR, White A, Elborn JS, Tunney MM.

Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):677-87.

PMID:
16249934
[PubMed - indexed for MEDLINE]
5.

Targeting a bacterial stress response to enhance antibiotic action.

Lee S, Hinz A, Bauerle E, Angermeyer A, Juhaszova K, Kaneko Y, Singh PK, Manoil C.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14570-5. doi: 10.1073/pnas.0903619106. Epub 2009 Aug 12.

PMID:
19706543
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Høiby N, Wretlind B.

Clin Microbiol Infect. 2009 Jan;15(1):60-6. doi: 10.1111/j.1469-0691.2008.02097.x. Epub 2008 Dec 22.

PMID:
19154484
[PubMed - indexed for MEDLINE]
7.

Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.

MacLeod DL, Nelson LE, Shawar RM, Lin BB, Lockwood LG, Dirk JE, Miller GH, Burns JL, Garber RL.

J Infect Dis. 2000 Mar;181(3):1180-4.

PMID:
10720551
[PubMed - indexed for MEDLINE]
Free Article
8.

Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.

Westbrock-Wadman S, Sherman DR, Hickey MJ, Coulter SN, Zhu YQ, Warrener P, Nguyen LY, Shawar RM, Folger KR, Stover CK.

Antimicrob Agents Chemother. 1999 Dec;43(12):2975-83.

PMID:
10582892
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.

McCaughey G, Gilpin DF, Schneiders T, Hoffman LR, McKevitt M, Elborn JS, Tunney MM.

Antimicrob Agents Chemother. 2013 Nov;57(11):5406-14. doi: 10.1128/AAC.00750-13. Epub 2013 Aug 19.

PMID:
23959314
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.

McCaughey G, Diamond P, Elborn JS, McKevitt M, Tunney MM.

PLoS One. 2013 Jul 25;8(7):e69763. doi: 10.1371/journal.pone.0069763. Print 2013.

PMID:
23936095
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility.

Marr AK, Overhage J, Bains M, Hancock RE.

Microbiology. 2007 Feb;153(Pt 2):474-82.

PMID:
17259618
[PubMed - indexed for MEDLINE]
Free Article
12.

Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).

Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.

J Antimicrob Chemother. 2008 Aug;62(2):316-23. doi: 10.1093/jac/dkn174. Epub 2008 May 8.

PMID:
18467306
[PubMed - indexed for MEDLINE]
Free Article
13.

Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.

Chuanchuen R, Wannaprasat W, Ajariyakhajorn K, Schweizer HP.

Microbiol Immunol. 2008 Aug;52(8):392-8. doi: 10.1111/j.1348-0421.2008.00051.x.

PMID:
18667038
[PubMed - indexed for MEDLINE]
14.

Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa.

Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K, Yagi T, Kato H, Arakawa Y.

Lancet. 2003 Dec 6;362(9399):1888-93.

PMID:
14667745
[PubMed - indexed for MEDLINE]
15.

Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Vogne C, Aires JR, Bailly C, Hocquet D, Plésiat P.

Antimicrob Agents Chemother. 2004 May;48(5):1676-80.

PMID:
15105120
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand.

Poonsuk K, Tribuddharat C, Chuanchuen R.

Can J Microbiol. 2013 Jan;59(1):51-6. doi: 10.1139/cjm-2012-0465. Epub 2012 Nov 19.

PMID:
23391230
[PubMed - indexed for MEDLINE]
17.

Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis.

Barclay ML, Begg EJ, Chambers ST, Thornley PE, Pattemore PK, Grimwood K.

J Antimicrob Chemother. 1996 Jun;37(6):1155-64.

PMID:
8836818
[PubMed - indexed for MEDLINE]
Free Article
18.

In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.

Karlowsky JA, Saunders MH, Harding GA, Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 1996 Jun;40(6):1387-93.

PMID:
8726006
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.

El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plésiat P.

Antimicrob Agents Chemother. 2007 Mar;51(3):1016-21. Epub 2006 Dec 28.

PMID:
17194835
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.

Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2006 Mar;50(3):975-83.

PMID:
16495260
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk